Kasper Ck

530 citations
7 papers · 397 · h-index 6

Impact in

  • Hematology top 2%
    • Hemophilia Treatment and Research
    • Platelet Disorders and Treatments
    • Blood Coagulation and Thrombosis Mechanisms
    • Hemostasis and retained surgical items
  • Genetics top 10%
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema
    • Virus-based gene therapy research

Papers in

    • Hemophilia Treatment and Research 6
    • Blood Coagulation and Thrombosis Mechanisms 4
    • Chronic Myeloid Leukemia Treatments 1
    • Platelet Disorders and Treatments 1
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema 3

Kasper Ck

7 papers receiving 383 citations

Peers

Kasper Ck
Comparison fields: 5 of 32
  • Hematology 348
  • Genetics 101
  • Immunology 35
  • Genetics 43
  • Internal Medicine 4
Replace L. M. Aledort with:
L. M. Aledort United States
van Eys J United States
V. Bony France
DA Galton United Kingdom
M. de Jesús Gallegos Santiago Spain
Erin L. Kuether United States
JP Fermand France
Véronique Dorvaux France
M. Hidajat Belgium
A.-L. Taksin France
Kasper Ck relative to L. M. Aledort United States L. M. Aledort's profile →
Citations per field
00.5×1.5×
L. M. Aledort · 1×
Citations per year

Countries citing papers authored by Kasper Ck

Since Specialization
Citations

This map shows the geographic impact of Kasper Ck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasper Ck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasper Ck more than expected).

Fields of papers citing papers by Kasper Ck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kasper Ck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasper Ck. The network helps show where Kasper Ck may publish in the future.

Co-authors

The 16 scholars most cited alongside Kasper Ck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kasper Ck Line = papers co-authored together Kasper Ck links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Proceedings: A more uniform measurement of factor VIII inhibitors.
1975279
2
Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.
199438
3
BLOOD CLOTTING FACTORS IN PREGNANCY: FACTOR 8 CONCENTRATIONS IN NORMAL AND AHF-DEFICIENT WOMEN.
196430
4 197922
5
Measurement of factor VIII inhibitors.
198414
6
Management of inhibitors to factor VIII.
198110
7
Comments on adverse reactions with recombinant factor VIII.
19914

About Kasper Ck

Kasper Ck is a scholar working on Hematology, Genetics, Pulmonary and Respiratory Medicine, Infectious Diseases and Organic Chemistry, having authored 7 papers that have together received 397 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Chronic Myeloid Leukemia Treatments (1 paper), Platelet Disorders and Treatments (1 paper) and Blood properties and coagulation (1 paper). The work is most often cited by research in Hematology (348 citations), Genetics (101 citations), Immunology (35 citations), Genetics (43 citations) and Internal Medicine (4 citations). Kasper Ck has collaborated with scholars based in United States and Italy. Frequent co-authors include Stewart Shapiro, Joseph C. Fratantoni, Richard W. Counts, Edson, L. M. Aledort, P. A. Levine, van Eys J, Campbell W. McMillan, M W Hilgartner and Jack Lazerson. Their work appears in journals such as Blood and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact